Jazz Pharmaceuticals Plc
(NASDAQ : JAZZ)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
0.10%19.7014.1%$436.29m
SAGESAGE Therapeutics, Inc.
2.72%162.3210.9%$216.91m
SHPGShire PLC Sponsored ADR
2.77%151.270.4%$168.46m
PRGOPerrigo Co. Plc
2.93%86.506.6%$88.44m
MNKMallinckrodt Plc
1.08%23.3618.5%$79.35m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.47%130.217.6%$59.41m
UTHRUnited Therapeutics Corporation
1.20%137.4114.5%$56.06m
JAZZJazz Pharmaceuticals Plc
0.02%135.532.2%$56.04m
ICPTIntercept Pharmaceuticals, Inc.
0.02%61.6222.0%$40.25m
RVNCRevance Therapeutics, Inc.
-0.31%32.0512.2%$36.88m
CTLTCatalent Inc
2.65%41.122.6%$36.60m
MDCOMedicines Company
0.18%27.3022.1%$36.53m
ADMSAdamas Pharmaceuticals, Inc.
1.56%32.5816.9%$36.42m
ENDPEndo International Plc
2.43%8.008.9%$33.43m
PTLAPortola Pharmaceuticals, Inc.
-1.12%47.027.8%$33.19m

Company Profile

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd on January 18, 2012 and is headquartered in Dublin, Ireland.